<p>Segmentation-induced changes benchmarked against published OCTA effect sizes reported for early diabetic retinopathy. For each OCTA metric, the table displays the typical pathological changes obser
Version 1Segmentation-induced changes benchmarked against published OCTA effect sizes reported for early diabetic retinopathy. For each OCTA metric, the table displays the typical pathological changes observed in early diabetic retinopathy (DR) based on meta-analytic evidence [18], along with the segmentation offset (in µm) required to reproduce an equivalent change in each device (DREAM, Cirrus, Triton). This table directly illustrates the clinical importance of segmentation variability by showing how s
No license available
Segmentation-induced changes benchmarked against published OCTA effect sizes reported for early diabetic retinopathy. For each OCTA metric, the table displays the typical pathological changes observed in early diabetic retinopathy (DR) based on meta-analytic evidence [18], along with the segmentation offset (in µm) required to reproduce an equivalent change in each device (DREAM, Cirrus, Triton). This table directly illustrates the clinical importance of segmentation variability by showing how s